β-Adrenergic receptor blockers and heart failure risk after myocardial infarction: A critical review

Current Heart Failure Reports

Volumn 6, Issue 4, 2009, Pages 220-228

  Hauptman, Paul J ^a   Neumayr, Robert H ^b  

^a SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALINIDINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METOPROLOL; PLACEBO; PROPRANOLOL; TIMOLOL;

CLINICAL TRIAL; DRUG ACTIVITY; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE REMODELING; HUMAN; LONG TERM CARE; MORTALITY; PRACTICE GUIDELINE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK REDUCTION; SHORT COURSE THERAPY; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE;

ADRENERGIC BETA-ANTAGONISTS; HEART FAILURE; HUMANS; MYOCARDIAL INFARCTION; RISK FACTORS; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 72449202346     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-009-0031-7     Document Type: Review

References (68)

1. D. Lloyd-Jones R. Adams M. Carnethon, et al. 2009 Heart Disease and Stroke Statistics-2009 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 119 e21 e181 10.1161/CIRCULATIONAHA.108.191261 19075105
2. L. Køer C. Torp-Pedersen S. Jørgensen, et al. 1998 Changes in absolute and relative importance in the prognostic value of left ventricular systolic function and congestive heart failure after acute myocardial infarction Am J Cardiol 81 1292 1297 10.1016/S0002-9149(98)00158-1 (Pubitemid 28268666)
3. P. Giannuzzi P.L. Temporelli E. Bosimini, et al. 2001 Heterogeneity of left ventricular remodeling after acute myocardial infarction. Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-3 Echo Substudy Am Heart J 141 131 138 10.1067/mhj.2001.111260 1:STN:280: DC%2BD3M7lsVWlsA%3D%3D 11136498 (Pubitemid 32061323)
4. P. Gaudron C. Eilles I. Kugler G. Ertl 1993 Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors Circulation 87 755 763 1:STN:280:DyaK3s7osFaisA%3D%3D 8443896
5. M.A. Pfeffer E. Braunwald L.A. Moye, et al. 1992 Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial N Engl J Med 327 669 677 1:STN:280:DyaK38zlslSrtQ%3D%3D 1386652
6. G.A. Lanza V. Guido M.M. Galeazzi, et al. 1998 Prognostic role of heart rate variability in patients with a recent acute myocardial infarction Am J Cardiol 82 1323 1328 10.1016/S0002-9149(98)00635-3 1:STN:280: DyaK1M%2Fnt1OgsQ%3D%3D 9856913 (Pubitemid 28565316)
7. R.Q. Migrino J.B. Young S.G. Ellis, et al. 1997 End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality Circulation 96 116 121 1:STN:280:DyaK2sznvFKhtA%3D%3D 9236425
8. A.H. Wu L. Parsons N.R. Every, et al. 2002 Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction. A report from the Second National Registry of Myocardial Infarction (NRMI-2) J Am Coll Cardiol 40 1389 1394 10.1016/S0735-1097(02)02173-3 12392826 (Pubitemid 35192861)
9. D. Hasdai E.J. Topol R. Kilaru, et al. 2003 Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials Am Heart J 145 73 79 10.1067/mhj.2003.53 12514657 (Pubitemid 36034500)
10. P.G. Steg O.H. Dabbous L.J. Feldman, et al. 2004 Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE) Circulation 109 494 499 10.1161/01.CIR.0000109691.16944.DA 14744970 (Pubitemid 38168512)
11. J.N. Cohn G.R. Johnson R. Shabetai, et al. 1993 Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group Circulation 87 VI5 VI16 1:STN:280: DyaK3s3nt1Cgtw%3D%3D 8500240
12. T. Wang D. Levy E. Benjamin R. Vasan 2003 The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening Ann Intern Med 138 907 916 12779301
13. T.A. McDonagh C.E. Morrison A. Lawrence, et al. 1997 Symptomatic and asymptomatic left ventricular systolic dysfunction in an urban population Lancet 350 829 833 10.1016/S0140-6736(97)03033-X 1:STN:280:DyaK2svls1KnsQ%3D%3D 9310600 (Pubitemid 27404343)
14. M. St John Sutton M.A. Pfeffer T. Plappert, et al. 1994 Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril Circulation 89 68 75 1:STN:280:DyaK2c7gvFSltA%3D%3D 8281697 (Pubitemid 24026473)
15. M.A. Konstam M.F. Rousseau M.W. Kronenberg, et al. 1992 Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators Circulation 86 431 438 1:STN:280:DyaK38zks1yhsg%3D%3D 1638712
16. B. Greenberg M.A. Quinones C. Koilpillai, et al. 1995 Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy Circulation 91 2573 2581 1:STN:280:DyaK2M3mt1agtg%3D%3D 7743619
17. M.A. Pfeffer G.A. Lamas D.E. Vaughan, et al. 1988 Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction N Engl J Med 319 80 86 1:STN:280:DyaL1c3ks1Ggsg%3D%3D 2967917
18. M.A. Pfeffer J.J. McMurray E.J. Velazquez, et al. 2003 Valsartan, captopril, or both in myocardial Infarction complicated by heart Failure, left ventricular dysfunction, or both N Engl J Med 349 1893 1906 10.1056/NEJMoa032292 1:CAS:528:DC%2BD3sXptVGnuro%3D 14610160 (Pubitemid 37409706)
19. B. Pitt W. Remme F. Zannad, et al. 2003 Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 1309 1321 10.1056/NEJMoa030207 1:CAS:528:DC%2BD3sXis1ehurY%3D 12668699 (Pubitemid 36384098)
20. M.R. Bristow 2000 Beta-adrenergic receptor blockade in chronic heart failure Circulation 101 558 569 1:CAS:528:DC%2BD3cXhtlajtrg%3D 10662755
21. D.L. Mann 1996 Stress activated cytokines and the heart Cytokine Growth Factor Rev 7 341 354 10.1016/S1359-6101(96)00043-3 1:CAS:528: DyaK2sXosFersg%3D%3D 9023057 (Pubitemid 27198070)
22. N. Spyrou S.D. Rosen F. Fath-Ordoubadi, et al. 2000 Myocardial beta-adrenoceptor density one month after acute myocardial infarction predicts left ventricular volumes at six months J Am Coll Cardiol 36 2072 2080 10.1016/S0735-1097(00)01006-8
23. J. Lopez-Sendon K. Swedberg J. McMurray, et al. 2004 Expert consensus document on beta-adrenergic receptor blockers Eur Heart J 25 1341 1362 10.1016/j.ehj.2004.06.002 15288162 (Pubitemid 39004105)
24. L. Ryden R. Ariniego K. Arnman, et al. 1983 A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias N Engl J Med 308 614 618 1:STN:280:DyaL3s7ktFKmtA%3D%3D 6828092
25. B.D. Lowes E.A. Gill W.T. Abraham, et al. 1999 Effects of carvedilol on left ventricular mass, chamber geometry and mitral regurgitation in chronic heart failure Am J Cardiol 83 1201 1205 10.1016/S0002-9149(99)00059-4 1:CAS:528:DyaK1MXivFSrsr0%3D 10215284 (Pubitemid 29183917)
26. S.A. Hall C.G. Cigarroa L. Marcoux, et al. 1995 Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade J Am Coll Cardiol 25 1154 1161 10.1016/0735-1097(94)00543-Y 1:STN:280:DyaK2M3gsVyhsA%3D%3D 7897129
27. S.H. Poulsen S.E. Jensen K. Egstrup 1999 Effects of long-term adrenergic beta-blockade on left ventricular diastolic filling in patients with acute myocardial infarction Am Heart J 138 710 720 10.1016/S0002-8703(99)70187-0 1:CAS:528:DyaK1MXmvVWit7s%3D 10502218 (Pubitemid 29471047)
28. S. Yusuf R. Peto J. Lewis, et al. 1985 Beta blockade during and after myocardial infarction: an overview of the randomized trials Prog Cardiovasc Dis 27 335 371 10.1016/S0033-0620(85)80003-7 1:STN:280:DyaL2M7ktFSitw%3D%3D 2858114 (Pubitemid 15107153)
29. First International Study of Infarct Survival Collaborative Group 1988 Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1 Lancet 1 921 923
30. First International Study of Infarct Survival Collaborative Group 1986 Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1 Lancet 2 57 66
31. MIAMI Trial Research Group 1985 Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial Eur Heart J 6 199 226
32. A. Hjalmarson J. Herlitz S. Holmberg, et al. 1983 The Goteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction Circulation 67 I26 I32 1:STN:280:DyaL3s3gslCjsQ%3D%3D 6342837
33. R. Roberts W.J. Rogers H.S. Mueller, et al. 1991 Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) II-B study Circulation 83 422 437 1:STN:280:DyaK3M7itFKlsw%3D%3D 1671346
34. F. Van de Werf L. Janssens T. Brzostek, et al. 1993 Short-term effect of early intravenous treatment with beta-adrenergic blocking agents or a specific bradycardia agent in patients with acute myocardial infarction receiving thrombolytic therapy J Am Coll Cardiol 22 407 416 8335810
35. M. Pfisterer J.L. Cox C.B. Granger, et al. 1998 Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries J Am Coll Cardiol 32 634 640 10.1016/S0735-1097(98)00279-4 1:CAS:528:DyaK1cXmt1Gqur8%3D 9741504 (Pubitemid 28435246)
36. Z.M. Chen H.C. Pan Y.P. Chen, et al. 2005 Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 1622 1632 10.1016/S0140-6736(05)67661-1 1:STN:280:DC%2BD2MrptlKmug%3D%3D 16271643 (Pubitemid 41552417)
37. A. Halkin C.L. Grines D.A. Cox, et al. 2004 Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction J Am Coll Cardiol 43 1780 1787 10.1016/j.jacc.2003.10.068 1:CAS:528:DC%2BD2cXktVCms7c%3D 15145099 (Pubitemid 38622514)
38. S.J. Kernis K.J. Harjai G.W. Stone, et al. 2004 Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty? J Am Coll Cardiol 43 1773 1779 10.1016/j.jacc.2003.09.071 1:CAS:528:DC%2BD2cXktVCms7Y%3D 15145098 (Pubitemid 38622513)
39. N. Freemantle J. Cleland P. Young, et al. 1999 Beta blockade after myocardial infarction: systematic review and metaregression analysis BMJ 318 1730 1737 1:STN:280:DyaK1MzhtVOhuw%3D%3D 10381708
40. Norwegian Multicenter Study Group 1981 Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction N Engl J Med 304 801 807
41. Beta-Blocker Heart Attack Trial Research Group 1982 A randomized trial of propranolol in patients with acute myocardial infarction JAMA 247 1707 1714 10.1001/jama.247.12.1707 (Pubitemid 12192963)
42. K. Chadda S. Goldstein R. Byington J.D. Curb 1986 Effect of propranolol after acute myocardial infarction in patients with congestive heart failure Circulation 73 503 510 1:STN:280:DyaL287jsVSmtw%3D%3D 3948357 (Pubitemid 16133029)
43. H.J. Dargie 2001 Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial Lancet 357 1385 1390 10.1016/S0140-6736(00)04560-8 1:CAS:528:DC%2BD3MXjsFWntro%3D 11356434 (Pubitemid 32455364)
44. S.S. Gottlieb R.J. McCarter R.A. Vogel 1998 Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction N Engl J Med 339 489 497 10.1056/NEJM199808203390801 1:STN:280: DyaK1czmtlKlsg%3D%3D 9709041 (Pubitemid 28384881)
45. B. Dahlöf P.S. Sever N.R. Poulter, et al. 2005 Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial Lancet 366 895 906 10.1016/S0140-6736(05)67185-1 16154016 (Pubitemid 41265663)
46. B. Carlberg O. Samuelsson L.H. Lindholm 2004 Atenolol in hypertension: is it a wise choice? Lancet 364 1684 1689 10.1016/S0140-6736(04)17355-8 1:CAS:528:DC%2BD2cXpsVKht78%3D 15530629 (Pubitemid 39458144)
47. P.A. Poole-Wilson K. Swedberg J.G. Cleland, et al. 2003 Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): a randomised controlled trial Lancet 362 7 13 10.1016/S0140-6736(03)13800-7 1:CAS:528:DC%2BD3sXltF2isrs%3D 12853193 (Pubitemid 36835815)
48. I.B. Mrdovic L.Z. Savic J.P. Perunicic, et al. 2007 Randomized active-controlled study comparing effects of treatment with carvedilol versus metoprolol in patients with left ventricular dysfunction after acute myocardial infarction Am Heart J 154 116 122 10.1016/j.ahj.2007.03.049 1:CAS:528: DC%2BD2sXmvVOjtb4%3D 17584563 (Pubitemid 46924803)
49. L. Pilote M. Abrahamowicz M. Eisenberg, et al. 2008 Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure CMAJ 178 1303 1311 18458262
50. J.K. Kjekshus 1986 Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials Am J Cardiol 57 43F 49F 10.1016/0002-9149(86)90888-X 1:STN:280: DyaL283htFyqtg%3D%3D 2871745
51. M. Cucherat 2007 Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials Eur Heart J 28 3012 3019 10.1093/eurheartj/ehm489 17981830 (Pubitemid 350262265)
52. D.T. Ko P.R. Hebert C.S. Coffey, et al. 2002 Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction JAMA 288 351 357 10.1001/jama.288.3.351 1:CAS:528:DC%2BD38Xltlegs7c%3D 12117400
53. R.P. Byington J. Worthy T. Craven, et al. 1990 Propranolol-induced lipid changes and their prognostic significance after a myocardial infarction: the beta-blocker Heart Attack Trial experience Am J Cardiol 65 1287 1291 10.1016/0002-9149(90)91314-V 1:STN:280:DyaK3c3mtFKhug%3D%3D 2188492 (Pubitemid 20172491)
54. G.C. Fonarow W.T. Abraham N.M. Albert, et al. 2007 Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) Arch Intern Med 167 1493 1502 10.1001/archinte.167.14.1493 17646603 (Pubitemid 47134697)
55. H.L. Kennedy M.M. Brooks A.H. Barker, et al. 1994 Beta-blocker therapy in the Cardiac Arrhythmia Suppression Trial. CAST Investigators Am J Cardiol 74 674 680 10.1016/0002-9149(94)90308-5 1:STN:280:DyaK2M%2FivFShsg%3D%3D 7942525 (Pubitemid 24298920)
56. T.R. Pedersen 1985 Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction N Engl J Med 313 1055 1058 1:STN:280:DyaL28%2FhsVanug%3D%3D 2864634
57. G. Olsson A. Oden L. Johansson, et al. 1988 Prognosis after withdrawal of chronic post-infarction metoprolol treatment. A 2 to 7 year follow-up Eur Heart J 9 365 372 1:STN:280:DyaL1c3lsVymtw%3D%3D 3383875
58. C.M. Viscoli R.I. Horwitz B.H. Singer 1993 Beta-blockers after myocardial infarction: influence of first-year clinical course on long-term effectiveness Ann Intern Med 118 99 105 1:STN:280:DyaK3s%2FpvVGgsA%3D%3D 8416325
59. H.M. Krumholz M.J. Radford Y. Wang, et al. 1998 National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project JAMA 280 623 629 10.1001/jama.280.7.623 1:CAS:528:DyaK1cXlslGqsLc%3D 9718054 (Pubitemid 28502639)
60. D. Hasdai S. Behar L. Wallentin, et al. 2002 A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS) Eur Heart J 23 1190 1201 10.1053/euhj.2002.3193 1:STN:280:DC%2BD38zotFyhtw%3D%3D 12127921 (Pubitemid 35215245)
61. P. Steg R. Goldberg J. Gore, et al. 2002 Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE) Am J Cardiol 90 358 363 10.1016/S0002-9149(02)02489-X 12161222 (Pubitemid 34895053)
62. J. Butler P.G. Arbogast R. BeLue, et al. 2002 Outpatient adherence to beta-blocker therapy after acute myocardial infarction J Am Coll Cardiol 40 1589 1595 10.1016/S0735-1097(02)02379-3 12427410 (Pubitemid 35253636)
63. G.H. Gislason J.N. Rasmussen S.Z. Abildstrom, et al. 2006 Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction Eur Heart J 27 1153 1158 10.1093/eurheartj/ehi705 1:CAS:528:DC%2BD28Xls1Crt7o%3D 16399775 (Pubitemid 43752385)
64. P.J. Hauptman 2008 Medication adherence in heart failure Heart Fail Rev 13 99 106 10.1007/s10741-007-9020-7 17479364 (Pubitemid 350278737)
65. E.M. Antman D.T. Anbe P.W. Armstrong 2004 ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction Circulation 110 e82 e293 10.1161/01.CIR.0000134791.68010.FA 15339869 (Pubitemid 39036178)
66. Canadian Cardiovascular Society American Academy of Family Physicians American College of Cardiology 2008 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction J Am Coll Cardiol 51 210 247 10.1016/j.jacc.2007.10.001
67. J.L. Anderson C.D. Adams E.M. Antman, et al. 2007 ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 50 e1 e157 10.1016/j.jacc.2007.02.013 17692738 (Pubitemid 47214564)
68. H. Seow C. Phillips M.W. Rich, et al. 2006 Isolation of health services research from practice and policy: the examples of chronic heart failure management J Am Geriatr Soc 54 535 540 10.1111/j.1532-5415.2005.00638.x 16551325 (Pubitemid 43327170)